M
MAIA Biotechnology, Inc. (MAIA)
ASE – Real vaqt narxi. Valyuta: USD
1.41
+0.06 (4.44%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.37
-0.04 (-2.84%)
Bozordan keyin: Jun 26, 2026, 6:20 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
1.41
+0.06 (4.44%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.37
-0.04 (-2.84%)
Bozordan keyin: Jun 26, 2026, 6:20 PM EDT
MAIA Biotechnology, Inc. o'z sho'ba korxonalari bilan birgalikda, klinik bosqichdagi biofarmatsevtika kompaniyasi, saraton uchun maqsadli immunoterapiyalarni ishlab chiqish bilan shug'ullanadi. Uning asosiy mahsuloti Ateganosine, telomerega yo'naltirilgan vosita, hozirda mayda hujayrali o'pka saratoni (NSCLC) dagi faolligini baholash uchun klinik rivojlanish bosqichida. Kompaniya 2018 yilda tashkil etilgan va shtab-kvartirasi Illinoys shtatining Chikago shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Sergei M. Gryaznov Ph.D. | Chief Scientific Officer |
| Dr. Vlad Vitoc M.B.A., M.D. | Co-Founder, President, CEO & Chairman of the Board of Directors |
| Linda Moreira | Company Secretary |
| Mr. Jeffrey C. Himmelreich M.B.A. | Head of Finance and Principal Financial & Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-22 | 8-K | form8-k.htm |
| 2026-05-19 | DEFA14A | formdefa14a.htm |
| 2026-05-14 | 8-K | form8-k.htm |
| 2026-05-11 | 10-Q | form10-q.htm |
| 2026-04-27 | DEFA14A | formdefa14a.htm |
| 2026-04-16 | 8-K | form8-k.htm |
| 2026-04-08 | 8-K | form8-k.htm |
| 2026-04-07 | S-8 | forms-8.htm |
| 2026-04-07 | DEF 14A | ny20065433x1_def14a.htm |
| 2026-04-07 | ARS | formars.pdf |